Saylor Strikes Again: Strategy Bags Another 4,980 Bitcoin in Latest Buying Spree
After teasing another move early Sunday, Strategy head Michael Saylor confirmed the next day that his firm scooped up an
Read more
Strategy
Mitbegründer von Strategy deutet weiteren Kauf von BTC an
Der Mitbegründer von Strategy, Michael Saylor, gab bekannt, dass das Unternehmen seit dem 14. April die elfte Woche in Folge
Read more
Spanish Coffee Shop Franchise Joins the Bitcoin Treasury Craze: Approves €1B Purchase Strategy
Spanish franchise Vanadi Coffee is now ready to execute its bitcoin purchase strategy and cryptocurrency pivot following the approval of
Read more
From Skepticism to Strategy: NYC Embraces Blockchain’s Civic Potential
The recent inaugural NYC Digital Asset Summit Roundtable, hosted by Mayor Eric Adams, focused on New York City’s strategy for
Read more
Crypto exchange Bakkt files to raise up to $1 billion to support Bitcoin strategy
Key Takeaways Bakkt filed a shelf registration to raise up to $1 billion for its Bitcoin and digital asset strategy.
Read more
Strategy Boss Michael Saylor Maps 21-Year Journey to $21M Bitcoin at BTC Prague
At BTC Prague 2025, Strategy Executive Chair Michael Saylor told a large crowd of bitcoin supporters he expects the leading
Read more
The Smarter Web Company Expands Bitcoin Holdings as Part of Long-Term Strategy
The Smarter Web Company, a London-listed technology firm, has announced the purchase of an additional 196.9 bitcoin as part of
Read more
Strategy Adds 245 Bitcoin, Totaling 592,345 BTC Amid Geopolitical and Market Turmoil
Amid global instability and market volatility, Strategy expands its bitcoin holdings with a $26 million acquisition, driving its stash to
Read more
Michael Saylor’s Strategy makes smallest Bitcoin purchase since mid-March
Key Takeaways Strategy purchased 245 BTC at an average price of $105,856, now holding 592,345 BTC valued above $60 billion.
Read more
Digital Shift: Parataxis Capital Bets on BTC Strategy in Korean Markets
Parataxis Holdings LLC has agreed to invest nearly $18.3 million (KRW 25 billion) in South Korea’s Bridge Biotherapeutics, gaining a
Read more